Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FES | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TIMM17B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SOX6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PRADC1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TSNARE1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CCNI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | EXOC8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HS3ST5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FADS2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CD300LF | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |